M. I. Leite, IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis, Brain, vol.131, issue.7, pp.1940-1952, 2008.

P. Devic, Antibodies to clustered acetylcholine receptor: expanding the phenotype, Eur. J. Neurol, vol.21, issue.1, pp.130-134, 2014.

S. Schiaffino and C. Reggiani, Fiber types in mammalian skeletal muscles, Physiol. Rev, vol.91, issue.4, pp.1447-1531, 2011.

D. Pette and R. S. Staron, Myosin isoforms, muscle fiber types, and transitions, Microsc. Res. Tech, vol.50, issue.6, pp.500-509, 2000.

R. S. Beddington and E. J. Robertson, Anterior patterning in mouse, Trends Genet. TIG, vol.14, issue.7, pp.277-284, 1998.

A. G. Borycki, B. Brunk, S. Tajbakhsh, M. Buckingham, C. Chiang et al., Sonic hedgehog controls epaxial muscle determination through Myf5 activation, Dev. Camb. Engl, vol.126, issue.18, pp.4053-4063, 1999.

S. M. Abmayr and G. K. Pavlath, Myoblast fusion: lessons from flies and mice, Dev. Camb. Engl, vol.139, issue.4, pp.641-656, 2012.

P. S. Zammit, T. A. Partridge, and Z. Yablonka-reuveni, The skeletal muscle satellite cell: the stem cell that came in from the cold, J. Histochem. Cytochem. Off. J. Histochem. Soc, vol.54, issue.11, pp.1177-1191, 2006.

R. Bischoff, Proliferation of muscle satellite cells on intact myofibers in culture, Dev. Biol, vol.115, issue.1, pp.129-139, 1986.

D. D. Cornelison, B. B. Olwin, M. A. Rudnicki, and B. J. Wold, MyoD(-/-) satellite cells in single-fiber culture are differentiation defective and MRF4 deficient, Dev. Biol, vol.224, issue.2, pp.122-137, 2000.

A. Mauro, SATELLITE CELL OF SKELETAL MUSCLE FIBERS, J. Biophys. Biochem. Cytol, vol.9, issue.2, pp.493-495, 1961.

A. Renzini, A. Benedetti, M. Bouchè, L. Silvestroni, S. Adamo et al.,

. Moresi, Culture conditions influence satellite cell activation and survival of single myofibers, Eur. J. Transl. Myol, vol.28, issue.2, p.7567, 2018.

H. E. Huxley, Electron microscope studies of the organisation of the filaments in striated muscle, Biochim. Biophys. Acta, vol.12, issue.1, pp.387-394, 1953.

K. Yamamoto, H. Nakayama, K. Nunoi, and M. Fujishima, Interaction of calmodulin with troponin I and the troponin-tropomyosin-actin complex. Effect of Ca2+ and Sr2+ ions, Biochem. J, vol.241, issue.3, pp.905-909, 1987.

B. Allard, From excitation to intracellular Ca2+ movements in skeletal muscle: Basic aspects and related clinical disorders, Neuromuscul. Disord. NMD, vol.28, issue.5, pp.394-401, 2018.

H. Nishimune and K. Shigemoto, Practical Anatomy of the Neuromuscular Junction in Health and Disease, Neurol. Clin, vol.36, issue.2, pp.231-240, 2018.

P. Rigoard, Organisation structurale, moléculaire, formation et maturation de la jonction neuromusculaire, Neurochirurgie, vol.55, pp.34-42, 2009.

W. Lin, H. B. Sanchez, T. Deerinck, J. K. Morris, M. Ellisman et al., Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice, Proc. Natl. Acad. Sci. U. S. A, vol.97, issue.3, pp.1299-1304, 2000.

M. L. Reynolds and C. J. Woolf, Terminal Schwann cells elaborate extensive processes following denervation of the motor endplate, J. Neurocytol, vol.21, issue.1, pp.50-66, 1992.

P. M. Cruz, J. Palace, and D. Beeson, Inherited disorders of the neuromuscular junction: an update, J. Neurol, vol.261, issue.11, pp.2234-2243, 2014.

C. R. Slater, The Structure of Human Neuromuscular Junctions: Some Unanswered Molecular Questions, Int. J. Mol. Sci, vol.18, issue.10, 2017.

J. Verschuuren, E. Strijbos, and A. Vincent, Neuromuscular junction disorders, Handb. Clin. Neurol, vol.133, pp.447-466, 2016.

C. Shen, W. Xiong, and L. Mei, LRP4 in neuromuscular junction and bone development and diseases, Bone, vol.80, pp.101-108, 2015.

L. Shi, A. K. Fu, and N. Y. Ip, Molecular mechanisms underlying maturation and maintenance of the vertebrate neuromuscular junction, Trends Neurosci, vol.35, issue.7, pp.441-453, 2012.

S. J. Burden, M. G. Huijbers, and L. Remedio, Fundamental Molecules and Mechanisms for Forming and Maintaining Neuromuscular Synapses, Int. J. Mol. Sci, vol.19, issue.2, 2018.

M. Motomura and O. Higuchi, Rinsh? Shinkeigaku Clin. Neurol, vol.52, issue.11, pp.1303-1305, 2012.

S. Berrih-aknin, M. Frenkian-cuvelier, and B. Eymard, Diagnostic and clinical classification of autoimmune myasthenia gravis, J. Autoimmun, pp.143-148, 2014.

L. Schaeffer, A. De-kerchove-d'exaerde, and J. P. Changeux, Targeting transcription to the neuromuscular synapse, Neuron, vol.31, issue.1, pp.15-22, 2001.
URL : https://hal.archives-ouvertes.fr/hal-00077622

H. Wu, W. C. Xiong, and L. Mei, To build a synapse: signaling pathways in neuromuscular junction assembly, Dev. Camb. Engl, vol.137, issue.7, pp.1017-1033, 2010.

A. G. Engel, Congenital Myasthenic Syndromes in 2018, Curr. Neurol. Neurosci. Rep, vol.18, issue.8, p.46, 2018.

C. Legay, Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms, Ann. N. Y. Acad. Sci, vol.1413, issue.1, pp.104-110, 2018.
DOI : 10.1111/nyas.13595

B. Eymard, Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy-The French National Congenital Myasthenic Syndrome Network experience, Rev. Neurol, vol.169, pp.45-55, 2013.
DOI : 10.1016/j.nmd.2013.06.588

P. B. Shieh and S. J. Oh, Congenital Myasthenic Syndromes, Neurol. Clin, vol.36, issue.2, pp.367-378, 2018.

C. Shen, Antibodies against low-density lipoprotein receptorrelated protein 4 induce myasthenia gravis, J. Clin. Invest, vol.123, issue.12, pp.5190-5202, 2013.
DOI : 10.1172/jci66039

URL : http://www.jci.org/articles/view/66039/files/pdf

M. Yan, G. Xing, W. Xiong, and L. Mei, Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis, Ann. N. Y. Acad. Sci, vol.1413, issue.1, pp.126-135, 2018.
DOI : 10.1111/nyas.13573

B. Zhang, Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis, Arch. Neurol, vol.69, issue.4, pp.445-451, 2012.

J. Cossins, The search for new antigenic targets in myasthenia gravis, Ann. N. Y. Acad. Sci, vol.1275, issue.1, pp.123-128, 2012.
DOI : 10.1111/j.1749-6632.2012.06833.x

C. Gasperi, Anti-agrin autoantibodies in myasthenia gravis, Neurology, vol.82, issue.22, pp.1976-1983, 2014.
DOI : 10.1212/wnl.0000000000000478

B. Zhang, Autoantibodies to Agrin in Myasthenia Gravis Patients, PLoS ONE, vol.9, issue.3, 2014.
DOI : 10.1371/journal.pone.0091816

URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0091816&type=printable

Y. Kawakami, Anti-MuSK autoantibodies block binding of collagen Q to MuSK, Neurology, vol.77, issue.20, pp.1819-1826, 2011.

M. Z. Katarzyna, K. Belaya, M. Leite, W. Patrick, A. Vincent et al., Collagen Q-a potential target for autoantibodies in myasthenia gravis, J. Neurol. Sci, vol.348, issue.1-2, pp.241-244, 2015.

W. Wang, H. Hao, and F. Gao, Detection of multiple antibodies in myasthenia gravis and its clinical significance, Chin. Med. J. (Engl.), vol.123, issue.18, pp.2555-2558, 2010.

A. M. Yamamoto, Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients, Arch. Neurol, vol.58, issue.6, pp.885-890, 2001.

D. Beeson, Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits, Eur. J. Biochem, vol.215, issue.2, pp.229-238, 1993.

J. Cossins, Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations, Brain J. Neurol, vol.129, pp.2773-2783, 2006.
DOI : 10.1093/brain/awl219

URL : https://academic.oup.com/brain/article-pdf/129/10/2773/824978/awl219.pdf

M. I. Leite, IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis, Brain, vol.131, issue.7, pp.1940-1952, 2008.
DOI : 10.1093/brain/awn092

URL : https://academic.oup.com/brain/article-pdf/131/7/1940/13734185/awn092.pdf

M. I. Leite, P. Waters, and A. Vincent, Diagnostic use of autoantibodies in myasthenia gravis, Autoimmunity, vol.43, issue.5-6, pp.371-379, 2010.
DOI : 10.3109/08916930903541208

F. Melo, D. J. Carey, and E. Brandan, Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression, J. Cell. Biochem, vol.62, issue.2, pp.227-239, 1996.
DOI : 10.1002/(sici)1097-4644(199608)62:2<227::aid-jcb11>3.3.co;2-f

A. Vincent, Serological and experimental studies in different forms of myasthenia gravis, Ann. N. Y. Acad. Sci, vol.1413, issue.1, pp.143-153, 2018.

P. M. Rodriguez-cruz, S. Huda, P. López-ruiz, and A. Vincent, Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases, Exp. Neurol